What are the triggers and phenotypes in the pediatric age group that consensus, guidelines, and evidence suggest should be treated with topical therapies, and what symptomatic, historical, or skin-based findings suggest a need to intensify therapy?
Presenter
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine